Moonwalk Biosciences, Inc., 2026-09-14
An SEC Form D private-offering notice from South San Francisco, CA, a $70,249,973 filer-stated offering target in Biotech. Filed 2026-09-14. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Biotech company developing adipose-targeted RNA (siRNA) therapies for cardiometabolic diseases, including obesity.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Twin Health, Inc., 2026-09-16, $61.5M, Menlo Park, CA
- Conexeu Sciences Inc., 2026-09-15, $252K, Reno, NV
- DeskJockee, Inc., 2026-09-15, $150K, Petaluma, CA
- ROSE DIAGNOSTICS INC., 2026-09-15, $3M, Carlsbad, CA
- Hexamer Therapeutics, Inc, 2026-09-15, $2.5M, Pullman, WA
- DIM SUM FARM LLC, 2026-09-11, $12M, Union City, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.